NASDAQ · LICN

Lichen China Limited

$1.10 -$0.09 (-7.56%) 1D After hours

Key Metrics

$18.08M
Market cap
P/E · TTM
$809.00K
Revenue · TTM
−$21.96M
Net income
EPS · TTM $-168.47
Dividend yield
Free cash flow −$17.85M
Beta · 1Y 0.35
EBITDA · TTM −$21.23M
Gross margin 1,129.4%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 22
    From its May 12 high, the share price fell 90%.

    Peak close $8.63 on May 12; trough close $0.84 on May 22. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -90%
  • May 20
    The stock moved -61.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 20
  • Mar 23
    The stock moved +49.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 23

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$18.08M
Enterprise value
Shares outstanding16.4M
52-wk range$0.71 – $9.49
Avg volume · 20D149.3K
Net cash
Book value / share$541.18
ExchangeNASDAQ
About Lichen China Limited
IPO dateFeb 6, 2023
Employees410

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S22.35
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 1,129.4%
Operating -2,693.1%
Net -2,714.7%
FCF -2,206.3%
ROE / ROIC -30.6% · -49.9%

Financial Health

Current ratio7.73
Quick ratio7.73
Debt / equity
Debt / EBITDA
Net cash
Working capital$31.49M

Cash Flow · TTM

Operating CF −$17.85M
Capex $0
Free cash flow −$17.85M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

2.1
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-06-30 · computed by TickerWolf from SEC filings